All In Biotech

Drug Trial Radar · NCT03878771

PRF in Management of Chronic Multiple Oral Ulcers

Platelet Rich-plasma in Management of Chronic Multiple Oral Ulcers

Last checked: Nov 19, 2026Latest source record: Sep 7, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

804

Actual

Start

Mar 13, 2019

Primary completion

Apr 15, 2019

Study completion Apr 15, 2019

Sponsor

Lead sponsor
Beni-Suef UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Mar 18, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

PRF in orabase will be applied as a pack material on chronic oral ulcers of chronic multiple oral lesions compared to conventional topical steroid therapy with clobetasol propionate 0.05% in orabase. The outcomes measured are Pain alleviation as Primary outcome and Clinical improvement in terms of Ulcer size, Number and Mucositis score as Secondary outcomes. Time frame for outcomes assessment will be Daily for 7 Days regarding pain score and weekly for 2 weeks regarding clinical improvement.

Conditions

  • Oral Ulcer Due to Pemphius Vularis
  • Oral Ulcer Due to Benign Mucous Membrane Pemphioid
  • Oral Ulcer Due to Steven Johnson's Syndrome

Interventions

  • Platelet rich fibrin gel in OrabaseBiological

    applied on oral mucositis and /or ulcer 3 times per day

  • Dermovate cream in OrabaseDrug

    applied on oral mucositis and /or ulcer 3 times per day

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pain scoreTime frame: 1 week

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Eman Ahmed

    Banī Suwayf, Beni Suweif Governorate, Egypt

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.